Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.

ABSTRACT:

Purpose

Breast cancer-related lymphedema (BCRL) represents a significant concern for patients following breast cancer treatment, and assessment for BCRL represents a key component of survivorship efforts. Growing data has demonstrated the benefits of early detection and treatment of BCRL. Traditional diagnostic modalities are less able to detect reversible subclinical BCRL while newer techniques such as bioimpedance spectroscopy (BIS) have shown the ability to detect subclinical BCRL, allowing for early intervention and low rates of chronic BCRL with level I evidence. We present updated clinical practice guidelines for BIS utilization to assess for BCRL.

Methods and results

Review of the literature identified a randomized controlled trial and other published data which form

SUBMITTER: Shah C 

PROVIDER: S-EPMC9883343 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature